)
ISTH 2024
International Society on Thrombosis and Haemostasis (ISTH) Congress 2024
22–26 June 2024 | Bangkok, Thailand
One of the Broadest Portfolios in Haematology
HEMGENIX® (etranacogene dezaparvovec), IDELVION® (Coagulation Factor IX (Recombinant), Albumin Fusion Protein (rFIX-FP)), HAEMATE P® (Von Willebrand factor/factor VIII), VONCENTO® (Human Coagulation Factor VIII/Von Willebrand Factor Complex) and KCENTRA® (Prothrombin Complex Concentrate (Human)) are not registered and not approved for use in Thailand. Registration conditions differ internationally, please refer to the local Prescribing Information in your country.
Consult the CSL Behring Global Products List to see what is available.
Report an undesirable effect
If you encounter any side effect(s) to a CSL Behring product, please contact us.
CMD-MTL-0024
June 2024